Literature DB >> 11722598

Periodic fever (TRAPS) caused by mutations in the TNFalpha receptor 1 (TNFRSF1A) gene of three German patients.

A Rösen-Wolff1, H W Kreth, S Hofmann, K Höhne, G Heubner, D Möbius, F Zintl, M Gahr, J Roesler.   

Abstract

TNF-receptor-associated periodic syndrome (TRAPS) is a recently recognized disorder characterized by prolonged attacks of high fever and severe localized inflammation. TRAPS is caused by dominant mutations in the 55 kDa TNF receptor gene (TNFRSF1A). We here describe three German TRAPS patients of two families with Cys30-->Arg and Thr50-->Met mutations, respectively. Both mutations have already been observed before in other nonrelated families. The Thr50-->Met amino acid exchange, caused by an ACG-->ATG transition, has been reported in two other families of different ethnic background. The possibility that the ACG-->ATG sequence alteration is a mutational hot spot causing TRAPS is discussed. Furthermore, we describe and discuss the symptoms of our patients, possible inducers of febrile attacks, and treatments which the patients had received when their diagnoses were still unknown.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722598

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  [Tumour necrosis factor receptor-associated periodic syndrome. A rare differential diagnosis of multiple sclerosis].

Authors:  P Günther; K Minden; W Hermann; J-P Schneider; A Wagner
Journal:  Nervenarzt       Date:  2005-10       Impact factor: 1.214

2.  "Periodic fever" without fever: two cases of non-febrile TRAPS with mutations in the TNFRSF1A gene presenting with episodes of inflammation or monosymptomatic amyloidosis.

Authors:  T Kallinich; D Haffner; B Rudolph; R Schindler; S Canaan-Kühl; R Keitzer; G R Burmester; A Roesen-Wolff; J Roesler
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

3.  Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.

Authors:  A Caminero; M Comabella; X Montalban
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

Review 4.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

Review 5.  Monogenic autoinflammatory diseases: concept and clinical manifestations.

Authors:  Adriana Almeida de Jesus; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2013-04-09       Impact factor: 3.969

6.  Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.

Authors:  Ian Todd; Paul M Radford; Kelly-Ann Draper-Morgan; Richard McIntosh; Susan Bainbridge; Peter Dickinson; Lama Jamhawi; Marios Sansaridis; Mary L Huggins; Patrick J Tighe; Richard J Powell
Journal:  Immunology       Date:  2004-09       Impact factor: 7.397

Review 7.  Vision-threatening bilateral panuveitis and TRAPS in a child: an uncommon association.

Authors:  Lidia Cocho; Elena Urbaneja; José M Herreras
Journal:  Int Ophthalmol       Date:  2017-12-18       Impact factor: 2.029

8.  The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.

Authors:  H J Lachmann; R Papa; K Gerhold; L Obici; I Touitou; L Cantarini; J Frenkel; J Anton; I Kone-Paut; M Cattalini; B Bader-Meunier; A Insalaco; V Hentgen; R Merino; C Modesto; N Toplak; R Berendes; S Ozen; R Cimaz; A Jansson; P A Brogan; P N Hawkins; N Ruperto; A Martini; P Woo; M Gattorno
Journal:  Ann Rheum Dis       Date:  2013-08-21       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.